AcetaZOLAMIDE Tablets, USP, 125 mg, 100 count bottled, Rx Only, Distributed by: Advagen Pharma Limited, Plainsboro, NJ, Manufactured by Rubicon Research Private Limited, Thane, India NDC 72888-047-01

FDA recall notice · announced September 25, 2024 · Rubicon Research Private Limited

Class III FDA/FSIS Class III: use is not likely to cause adverse health consequences.

The product

AcetaZOLAMIDE Tablets, USP, 125 mg, 100 count bottled, Rx Only, Distributed by: Advagen Pharma Limited, Plainsboro, NJ, Manufactured by Rubicon Research Private Limited, Thane, India NDC 72888-047-01

Reason for recall

Discoloration

Notes

Distribution: Nationwide in the US
Lot/code information: Lot # 30575HF1, exp. date, Nov 2026 NDC# 72888-047-01
Quantity: 3,984 bottles
Status: Ongoing
Products in this recall event:
- AcetaZOLAMIDE Tablets, USP, 125 mg, 100 count bottled, Rx Only, Distributed by: Advagen Pharma Limited, Plainsboro, NJ, Manufactured by Rubicon Research Private Limited, Thane, India NDC 72888-047-01 (D-0659-2024)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.